GPT and thalassemia: Faiq et al. suggested that measurement of serum ALT and AST, be performed regularly to assess liver functioning in thalassemia patients, as an increase in these enzymes is indicative of liver damage.17 Moreover, bilirubin, produced by the breakdown of red cells, undergoes hepatic processing and accordingly, its level rises in liver damage.18